Resources

BDX – Market expectations are for Uniform ROA to remain at historical highs, but management’s concerns about revenue growth and cost synergies imply this may be unwarranted

September 12, 2017

  • Becton, Dickinson and Company (BDX:USA) is currently trading near historical highs relative to UAFRS-based (Uniform) Earnings, with an 18.0x Uniform P/E, implying fairly bullish expectations for the firm. However, given management’s concerns about revenue growth and cost synergies, this may be unwarranted
  • Specifically, management may lack confidence in their ability to achieve $350mn in cumulative cost synergies from the CareFusion acquisition by 2018. Moreover, they may lack confidence in their ability to drive low-double-digit growth in China for the full year, and in their ability to drive revenue growth of 4.5%-5.0% in BD Medical for the full year. Should the firm fail to sustain peak Uniform ROA, as management sentiment suggests, multiple compression and equity downside would be warranted

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683